Latest New Zealand News

Vulcan Steel reported a sharp profit decline in FY25 amid tough market conditions but strengthened its balance sheet and expanded into roofing with a major acquisition. Leadership changes set the stage for renewed growth.

Echelon Resources reported a solid quarter with production gains at Maari and Mahato fields, supported by new wells and a strategic gas sales agreement, while maintaining shareholder returns through dividends.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Aeris Resources has announced a significant $90 million equity raise through a placement and share purchase plan, aiming to strengthen its balance sheet and fund key growth projects. The raise comes with a discount to recent share prices and supports the company’s strategic expansion and operational improvements.

Aeris Resources has secured $80 million through an institutional placement and launched a $10 million share purchase plan, aiming to repay debt and accelerate key exploration projects.

GWA reported modest revenue and earnings growth in FY25, driven by strong performance in Australia and the UK despite a tough New Zealand market. The company also initiated a $30 million on-market share buyback and increased its fully franked dividend.

Steadfast Group Limited has posted a 17.2% rise in underlying net profit after tax for FY25, marking its 12th consecutive year of growth, even as its CEO steps aside pending an investigation. The company also announced a leadership transition with Vicki Allen named incoming Chair.

Novatti Group has achieved positive operating cashflow and EBITDA for the September quarter, driven by strategic revenue reforms and new commercial contracts with major clients.

BCAL Diagnostics has secured key partnerships and a $10 million convertible note facility to expand its cancer detection tests across Australia and New Zealand, marking steady commercial progress in Q3 2025.

Integral Diagnostics reports a robust FY25 with revenue climbing 33.7% to $628 million, driven by successful Capitol Health merger integration and strong growth in teleradiology. CEO Dr Ian Kadish announces retirement after eight transformative years.

Acusensus Limited has secured a significant expansion of its contract with Queensland’s Department of Transport and Main Roads, doubling its trailer-based speed enforcement units with a $16.6 million deal set to roll out from late 2025.

PainChek Ltd has achieved a pivotal FDA De Novo clearance for its AI-driven Adult pain assessment app, unlocking the US market and driving its annual recurring revenue to $5.6 million. The company also launched its Infant app, targeting a vast global market of pre-verbal children.